{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:56:03Z","timestamp":1779360963136,"version":"3.51.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/durrantlab.com\/autogrow4\">http:\/\/durrantlab.com\/autogrow4<\/jats:ext-link>.<\/jats:p>","DOI":"10.1186\/s13321-020-00429-4","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T12:02:34Z","timestamp":1587124954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization"],"prefix":"10.1186","volume":"12","author":[{"given":"Jacob O.","family":"Spiegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob D.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"429_CR1","doi-asserted-by":"publisher","DOI":"10.1021\/ci0255782","author":"P Ertl","year":"2003","unstructured":"Ertl P (2003) Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups. J Chem Inf Comput Sci. https:\/\/doi.org\/10.1021\/ci0255782","journal-title":"J Chem Inf Comput Sci"},{"key":"429_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6","author":"RS Bohacek","year":"1996","unstructured":"Bohacek RS, McMartin C, Guida WC (1996) The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev. https:\/\/doi.org\/10.1002\/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6","journal-title":"Med Res Rev"},{"key":"429_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-013-9672-4","author":"PG Polishchuk","year":"2013","unstructured":"Polishchuk PG, Madzhidov TI, Varnek A (2013) Estimation of the size of drug-like chemical space based on GDB-17 data. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-013-9672-4","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"429_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1747-0285.2008.00761.x","volume":"73","author":"JD Durrant","year":"2009","unstructured":"Durrant JD, Amaro RE, McCammon JA (2009) Autogrow: a novel algorithm for protein inhibitor design. Chem Biol Drug Des 73(2):168\u2013178. https:\/\/doi.org\/10.1111\/j.1747-0285.2008.00761.x","journal-title":"Chem Biol Drug Des"},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jmgm.2013.05.006","volume":"44","author":"JD Durrant","year":"2013","unstructured":"Durrant JD, Lindert S, McCammon JA (2013) Autogrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. J Mol Graph Model 44:104\u2013112. https:\/\/doi.org\/10.1016\/j.jmgm.2013.05.006","journal-title":"J Mol Graph Model"},{"key":"429_CR6","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007336","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"key":"429_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200800178","author":"J Degen","year":"2008","unstructured":"Degen J, Wegscheid-Gerlach C, Zaliani A, Rarey M (2008) On the art of compiling and using \u2019drug-like\u2019 chemical fragment spaces. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.200800178","journal-title":"ChemMedChem"},{"key":"429_CR8","first-page":"85","volume-title":"Antibiotics methods in molecular biology","author":"W Yu","year":"2017","unstructured":"Yu W, MacKerell AD (2017) Chap. 5. Computer-aided drug design methods. In: Sass P (ed) Antibiotics methods in molecular biology, vol 1520. Springer, Berlin, pp 85\u2013106"},{"key":"429_CR9","doi-asserted-by":"publisher","DOI":"10.1021\/ci400418c","author":"K Kawai","year":"2014","unstructured":"Kawai K, Nagata N, Takahashi Y (2014) De novo design of drug-like molecules by a fragment-based molecular evolutionary approach. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci400418c","journal-title":"J Chem Inf Model"},{"issue":"13","key":"429_CR10","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/bioinformatics\/btv082","volume":"31","author":"A Alhossary","year":"2015","unstructured":"Alhossary A, Handoko SD, Mu Y, Kwoh CK (2015) Fast, accurate, and reliable molecular docking with QuickVina 2. Bioinformatics 31(13):2214\u20132216. https:\/\/doi.org\/10.1093\/bioinformatics\/btv082","journal-title":"Bioinformatics"},{"issue":"1","key":"429_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13321-019-0358-3","volume":"11","author":"PJ Ropp","year":"2019","unstructured":"Ropp PJ, Spiegel JO, Walker JL, Green H, Morales GA, Milliken KA, Ringe JJ, Durrant JD (2019) Gypsum-dl: an open-source program for preparing small-molecule libraries for structure-based virtual screening. J Cheminform 11(1):34. https:\/\/doi.org\/10.1186\/s13321-019-0358-3","journal-title":"J Cheminform"},{"issue":"19","key":"429_CR12","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1158\/1078-0432.CCR-15-0887","volume":"21","author":"G Kim","year":"2015","unstructured":"Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, Sridhara R, Lee E, Tzou A, Philip R et al (2015) Fda approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy. Clin Cancer Res 21(19):4257\u20134261","journal-title":"Clin Cancer Res"},{"issue":"23","key":"429_CR13","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/1078-0432.CCR-17-1337","volume":"23","author":"S Balasubramaniam","year":"2017","unstructured":"Balasubramaniam S, Beaver JA, Horton S, Fernandes LL, Tang S, Horne HN, Liu J, Liu C, Schrieber SJ, Yu J, Song P, Pierce W, Robertson KJ, Palmby TR, Chiu HJ, Lee EY, Philip R, Schuck R, Charlab R, Banerjee A, Chen XH, Wang X, Goldberg KB, Sridhara R, Kim G, Pazdur R (2017) FDA approval summary: rucaparib for the treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer. Clin Cancer Res 23(23):7165\u20137170. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1337","journal-title":"Clin Cancer Res"},{"issue":"17","key":"429_CR14","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1158\/1078-0432.CCR-18-0042","volume":"24","author":"G Ison","year":"2018","unstructured":"Ison G, Howie LJ, Amiri-Kordestani L, Zhang L, Tang S, Sridhara R, Pierre V, Charlab R, Ramamoorthy A, Song P, Li F, Yu J, Manheng W, Palmby TR, Ghosh S, Horne HN, Lee EY, Philip R, Dave K, Chen XH, Kelly SL, Janoria KG, Banerjee A, Eradiri O, Dinin J, Goldberg KB, Pierce WF, Ibrahim A, Kluetz PG, Blumenthal GM, Beaver JA, Pazdur R (2018) FDA approval summary: niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy. Clin Cancer Res 24(17):4066\u20134071. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0042","journal-title":"Clin Cancer Res"},{"issue":"18","key":"429_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s40265-018-1026-z","volume":"78","author":"SM Hoy","year":"2018","unstructured":"Hoy SM (2018) Talazoparib: first global approval. Drugs 78(18):1939\u20131946. https:\/\/doi.org\/10.1007\/s40265-018-1026-z","journal-title":"Drugs"},{"issue":"3","key":"429_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ygyno.2017.10.003","volume":"147","author":"BG Bitler","year":"2017","unstructured":"Bitler BG, Watson ZL, Wheeler LJ, Behbakht K (2017) PARP inhibitors: clinical utility and possibilities of overcoming resistance. Gynecol Oncol 147(3):695\u2013704. https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.003","journal-title":"Gynecol Oncol"},{"issue":"8","key":"429_CR17","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1073\/pnas.1013715108","volume":"108","author":"AG Patel","year":"2011","unstructured":"Patel AG, Sarkaria JN, Kaufmann SH (2011) Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc Nat Acad Sci USA 108(8):3406\u20133411. https:\/\/doi.org\/10.1073\/pnas.1013715108","journal-title":"Proc Nat Acad Sci USA"},{"key":"429_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00990","author":"AG Thorsell","year":"2017","unstructured":"Thorsell AG, Ekblad T, Karlberg T, L\u00f6w M, Pinto AF, Tr\u00e9saugues L, Moche M, Cohen MS, Sch\u00fcler H (2017) Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00990","journal-title":"J Med Chem"},{"issue":"5","key":"429_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","volume":"60","author":"JM Dawicki-McKenna","year":"2015","unstructured":"Dawicki-McKenna JM, Langelier M-F, DeNizio JE, Riccio AA, Cao CD, Karch KR, McCauley M, Steffen JD, Black BE, Pascal JM (2015) Parp-1 activation requires local unfolding of an autoinhibitory domain. Mol Cell 60(5):755\u2013768. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.013","journal-title":"Mol Cell"},{"issue":"1\u20133","key":"429_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0014-5793(03)01362-0","volume":"556","author":"T Kinoshita","year":"2004","unstructured":"Kinoshita T, Nakanishi I, Warizaya M, Iwashita A, Kido Y, Hattori K, Fujii T (2004) Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase. FEBS Lett 556(1\u20133):43\u20136. https:\/\/doi.org\/10.1016\/s0014-5793(03)01362-0","journal-title":"FEBS Lett"},{"issue":"2","key":"429_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"429_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002397","author":"JD Durrant","year":"2012","unstructured":"Durrant JD, McCammon JA (2012) Autoclickchem: click chemistry in silico. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1002397","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"429_CR23","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1021\/ci200379p","volume":"51","author":"M Hartenfeller","year":"2011","unstructured":"Hartenfeller M, Eberle M, Meier P, Nieto-Oberhuber C, Altmann KH, Schneider G, Jacoby E, Renner S (2011) A collection of robust organic synthesis reactions for in silico molecule design. J Chem Inf Model 51(12):3093\u20133098. https:\/\/doi.org\/10.1021\/ci200379p","journal-title":"J Chem Inf Model"},{"key":"429_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00559","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15-ligand discovery for everyone. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"issue":"3","key":"429_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1747-0285.2012.01414.x","volume":"80","author":"S Lindert","year":"2012","unstructured":"Lindert S, Durrant JD, Mccammon JA (2012) LigMerge: a fast algorithm to generate models of novel potential ligands from sets of known binders. Chem Biol Drug Des 80(3):358\u2013365. https:\/\/doi.org\/10.1111\/j.1747-0285.2012.01414.x","journal-title":"Chem Biol Drug Des"},{"key":"429_CR26","unstructured":"Landrum G RDKit: open-source cheminformatics. http:\/\/www.rdkit.org\/"},{"issue":"1","key":"429_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13321-019-0336-9","volume":"11","author":"PJ Ropp","year":"2019","unstructured":"Ropp PJ, Kaminsky JC, Yablonski S, Durrant JD (2019) Dimorphite-DL: an open-source program for enumerating the ionization states of drug-like small molecules. J Cheminform 11(1):14. https:\/\/doi.org\/10.1186\/s13321-019-0336-9","journal-title":"J Cheminform"},{"issue":"10","key":"429_CR28","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1021\/ci100244v","volume":"50","author":"JD Durrant","year":"2010","unstructured":"Durrant JD, McCammon JA (2010) NNScore: a neural-network-based scoring function for the characterization of protein\u2013ligand complexes. J Chem Inf Model 50(10):1865\u20131871. https:\/\/doi.org\/10.1021\/ci100244v","journal-title":"J Chem Inf Model"},{"issue":"11","key":"429_CR29","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1021\/ci2003889","volume":"51","author":"JD Durrant","year":"2011","unstructured":"Durrant JD, McCammon JA (2011) Nnscore 2.0: a neural-network receptor-ligand scoring function. J Chem Inf Model 51(11):2897\u20132903. https:\/\/doi.org\/10.1021\/ci2003889","journal-title":"J Chem Inf Model"},{"issue":"8","key":"429_CR30","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/jm701255b","volume":"51","author":"CH Reynolds","year":"2008","unstructured":"Reynolds CH, Tounge BA, Bembenek SD (2008) Ligand binding efficiency: trends, physical basis, and implications. J Med Chem 51(8):2432\u20132438","journal-title":"J Med Chem"},{"key":"429_CR31","unstructured":"Landrum G (2011) Getting started with the RDKit in Python. https:\/\/www.rdkit.org\/docs\/GettingStartedInPython.html"},{"key":"429_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-015-0069-3","author":"D Bajusz","year":"2015","unstructured":"Bajusz D, R\u00e1cz A, H\u00e9berger K (2015) Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminform. https:\/\/doi.org\/10.1186\/s13321-015-0069-3","journal-title":"J Cheminform"},{"key":"429_CR33","doi-asserted-by":"publisher","unstructured":"Shukla A, Pandey HM, Mehrotra D (2015) Comparative review of selection techniques in genetic algorithm. In: 2015 international conference on futuristic trends on computational analysis and knowledge management (ABLAZE) (February), pp 515\u2013519. https:\/\/doi.org\/10.1109\/ABLAZE.2015.7154916","DOI":"10.1109\/ABLAZE.2015.7154916"},{"key":"429_CR34","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444902003451","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C (2002) The protein data bank. Acta Crystallogr Sect D Biol Crystallogr. https:\/\/doi.org\/10.1107\/S0907444902003451","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"issue":"Web Server issu","key":"429_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) Pdb2pqr: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucl Acids Res 32(Web Server issue):665\u2013667. https:\/\/doi.org\/10.1093\/nar\/gkh381","journal-title":"Nucl Acids Res"},{"issue":"Web Server issu","key":"429_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA (2007) Pdb2pqr: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucl Acids Res 35(Web Server issue):522\u2013525. https:\/\/doi.org\/10.1093\/nar\/gkm276","journal-title":"Nucl Acids Res"},{"key":"429_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"429_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-017-0237-8","author":"P Ropp","year":"2017","unstructured":"Ropp P, Friedman A, Durrant JD (2017) Scoria: a Python module for manipulating 3D molecular data. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-017-0237-8","journal-title":"J Cheminform"},{"issue":"13","key":"429_CR39","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1093\/bioinformatics\/bty968","volume":"35","author":"JD Durrant","year":"2018","unstructured":"Durrant JD (2018) Blendmol: advanced macromolecular visualization in blender. Bioinformatics 35(13):2323\u20132325. https:\/\/doi.org\/10.1093\/bioinformatics\/bty968","journal-title":"Bioinformatics"},{"issue":"7","key":"429_CR40","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/jm051209w","volume":"49","author":"JK Alvesalo","year":"2006","unstructured":"Alvesalo JK, Siiskonen A, Vainio MJ, Tammela PS, Vuorela PM (2006) Similarity based virtual screening: a tool for targeted library design. J Med Chem 49(7):2353\u20132356","journal-title":"J Med Chem"},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fchem.2020.00093","volume":"8","author":"LR de Souza Neto","year":"2020","unstructured":"de Souza Neto LR, Moreira-Filho JT, Neves BJ, Maidana RLBR, Guimar\u00e3es ACR, Furnham N, Andrade CH, Silva FP Jr (2020) In silico strategies to support fragment-to-lead optimization in drug discovery. Front Chem 8:93","journal-title":"Front Chem"},{"issue":"1","key":"429_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/bioinformatics\/18.1.130","volume":"18","author":"X Chen","year":"2002","unstructured":"Chen X, Lin Y, Liu M, Gilson MK (2002) The binding database: data management and interface design. Bioinformatics 18(1):130\u2013139. https:\/\/doi.org\/10.1093\/bioinformatics\/18.1.130","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"429_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein\u2013ligand binding affinities. Nucl Acids Res 35(Database issue):198\u2013201. https:\/\/doi.org\/10.1093\/nar\/gkl999","journal-title":"Nucl Acids Res"},{"issue":"4","key":"429_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina D (1999) Unsupervised data base clustering based on daylight\u2019s fingerprint and tanimoto similarity: a fast and automated way to cluster small and large data sets. J Chem Inf Comput Sci 39(4):747\u2013750","journal-title":"J Chem Inf Comput Sci"},{"issue":"Web Server issu","key":"429_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH (2009) Pubchem: a public information system for analyzing bioactivities of small molecules. Nucl Acids Res 37(Web Server issue):623\u201333. https:\/\/doi.org\/10.1093\/nar\/gkp456","journal-title":"Nucl Acids Res"},{"key":"429_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cotox.2017.10.009","volume":"7","author":"B Van Houten","year":"2018","unstructured":"Van Houten B, Santa-Gonzalez GA, Camargo M (2018) DNA repair after oxidative stress: current challenges. Curr Opin Toxicol 7:9\u201316. https:\/\/doi.org\/10.1016\/j.cotox.2017.10.009","journal-title":"Curr Opin Toxicol"},{"issue":"1","key":"429_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/cr.2008.8","volume":"18","author":"ML Hegde","year":"2008","unstructured":"Hegde ML, Hazra TK, Mitra S (2008) Early steps in the dna base excision\/single-strand interruption repair pathway in mammalian cells. Cell Res 18(1):27","journal-title":"Cell Res"},{"issue":"6835","key":"429_CR48","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366","journal-title":"Nature"},{"issue":"8","key":"429_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HH Chang","year":"2017","unstructured":"Chang HH, Pannunzio NR, Adachi N, Lieber MR (2017) Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol 18(8):495","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"429_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1083\/jcb.201012132","volume":"194","author":"CA-M Couto","year":"2011","unstructured":"Couto CA-M, Wang H-Y, Green JCA, Kiely R, Siddaway R, Borer C, Pears CJ, Lakin ND (2011) PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks. J Cell Biol 194(3):367\u2013375. https:\/\/doi.org\/10.1083\/jcb.201012132","journal-title":"J Cell Biol"},{"issue":"5","key":"429_CR51","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1128\/MCB.21.5.1828","volume":"21","author":"M Mark","year":"2001","unstructured":"Mark M, Wendling O, Wynshaw-boris JMEA (2001) Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Microbiology 21(5):1828\u20131832. https:\/\/doi.org\/10.1128\/MCB.21.5.1828","journal-title":"Microbiology"},{"issue":"7011","key":"429_CR52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nature02964","volume":"431","author":"G Ira","year":"2004","unstructured":"Ira G, Pellicioll A, Balijja A, Wang X, Florani S, Carotenuto W, Liberi G, Bressan D, Wan L, Hollingsworth NM, Haber JE, Folani M (2004) DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 431(7011):1011\u20131017. https:\/\/doi.org\/10.1038\/nature02964","journal-title":"Nature"},{"issue":"8","key":"429_CR53","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/nar\/gkz120","volume":"47","author":"EE Alemasova","year":"2019","unstructured":"Alemasova EE, Lavrik OI (2019) Poly (ADP-ribosyl) ation by PARP1: reaction mechanism and regulatory proteins. Nucl Acids Res 47(8):3811\u20133827","journal-title":"Nucl Acids Res"},{"issue":"1","key":"429_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. J Comb Chem 1(1):55\u201368. https:\/\/doi.org\/10.1021\/cc9800071","journal-title":"J Comb Chem"},{"key":"429_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011955","author":"MW Chang","year":"2010","unstructured":"Chang MW, Ayeni C, Breuer S, Torbett BE (2010) Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0011955","journal-title":"PLoS ONE"},{"issue":"3","key":"429_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, Wyatt PG (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3(3):435\u2013444. https:\/\/doi.org\/10.1002\/cmdc.200700139","journal-title":"ChemMedChem"},{"key":"429_CR57","unstructured":"Casas N (2015) Genetic algorithms for multimodal optimization: a review"},{"issue":"17","key":"429_CR58","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1021\/jm0499256","volume":"47","author":"K Hattori","year":"2004","unstructured":"Hattori K, Kido Y, Yamamoto H, Ishida J, Kamijo K, Murano K, Ohkubo M, Kinoshita T, Iwashita A, Mihara K, Yamazaki S, Matsuoka N, Teramura Y, Miyake H (2004) Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase. J Med Chem 47(17):4151\u20134. https:\/\/doi.org\/10.1021\/jm0499256","journal-title":"J Med Chem"},{"issue":"7","key":"429_CR59","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1021\/jm301825t","volume":"56","author":"N Ye","year":"2013","unstructured":"Ye N, Chen C-H, Chen T, Song Z, He J-X, Huan X-J, Song S-S, Liu Q, Chen Y, Ding J, Xu Y, Miao Z-H, Zhang A (2013) Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8h)-ones bearing a functionalized longer chain appendage as novel parp1 inhibitors. J Med Chem 56(7):2885\u2013903. https:\/\/doi.org\/10.1021\/jm301825t","journal-title":"J Med Chem"},{"issue":"8","key":"429_CR60","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1021\/cb4002014","volume":"8","author":"AEG Lindgren","year":"2013","unstructured":"Lindgren AEG, Karlberg T, Thorsell A-G, Hesse M, Spjut S, Ekblad T, Andersson CD, Pinto AF, Weigelt J, Hottiger MO, Linusson A, Elofsson M, Sch\u00fcler H (2013) PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3\/PARP3. ACS Chem Biol 8(8):1698\u2013703. https:\/\/doi.org\/10.1021\/cb4002014","journal-title":"ACS Chem Biol"},{"issue":"13","key":"429_CR61","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1021\/jm5002502","volume":"57","author":"MR Patel","year":"2014","unstructured":"Patel MR, Bhatt A, Steffen JD, Chergui A, Murai J, Pommier Y, Pascal JM, Trombetta LD, Fronczek FR, Talele TT (2014) Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2h)-one-7-carboxamide derivatives as poly(adp-ribose)polymerase-1 inhibitors. J Med Chem 57(13):5579\u2013601. https:\/\/doi.org\/10.1021\/jm5002502","journal-title":"J Med Chem"},{"issue":"Pt 9","key":"429_CR62","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1107\/S2053230X14015088","volume":"70","author":"M Aoyagi-Scharber","year":"2014","unstructured":"Aoyagi-Scharber M, Gardberg AS, Yip BK, Wang B, Shen Y, Fitzpatrick PA (2014) Structural basis for the inhibition of poly(adp-ribose) polymerases 1 and 2 by bmn 673, a potent inhibitor derived from dihydropyridophthalazinone. Acta Crystallogr F Struct Biol Commun 70(Pt 9):1143\u20139. https:\/\/doi.org\/10.1107\/S2053230X14015088","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"17","key":"429_CR63","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1021\/acs.jmedchem.5b00680","volume":"58","author":"G Papeo","year":"2015","unstructured":"Papeo G, Posteri H, Borghi D, Busel AA, Caprera F, Casale E, Ciomei M, Cirla A, Corti E, D\u2019Anello M, Fasolini M, Forte B, Galvani A, Isacchi A, Khvat A, Krasavin MY, Lupi R, Orsini P, Perego R, Pesenti E, Pezzetta D, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Sola F, Zuccotto F, Felder ER, Donati D, Montagnoli A (2015) Discovery of 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1h-isoindole-4-carboxamide (nms-p118): a potent, orally available, and highly selective PARP-1 inhibitor for cancer therapy. J Med Chem 58(17):6875\u201398. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00680","journal-title":"J Med Chem"},{"issue":"1","key":"429_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41598-016-0007-2","volume":"6","author":"L Fu","year":"2016","unstructured":"Fu L, Wang S, Wang X, Wang P, Zheng Y, Yao D, Guo M, Zhang L, Ouyang L (2016) Crystal structure-based discovery of a novel synthesized parp1 inhibitor (ol-1) with apoptosis-inducing mechanisms in triple-negative breast cancer. Sci Rep 6(1):3. https:\/\/doi.org\/10.1038\/s41598-016-0007-2","journal-title":"Sci Rep"},{"key":"429_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejmech.2018.01.018","volume":"145","author":"X Chen","year":"2018","unstructured":"Chen X, Huan X, Liu Q, Wang Y, He Q, Tan C, Chen Y, Ding J, Xu Y, Miao Z, Yang C (2018) Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious poly(ADP-ribose)polymerase (PARP) inhibitors. Eur J Med Chem 145:389\u2013403. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.018","journal-title":"Eur J Med Chem"},{"key":"429_CR66","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1021\/acs.jmedchem.8b01709","volume":"62","author":"UK Velagapudi","year":"2019","unstructured":"Velagapudi UK, Langelier M-F, Delgado-Martin C, Diolaiti ME, Bakker S, Ashworth A, Patel BA, Shao X, Pascal JM, Talele TT (2019) Design and synthesis of poly (ADP-ribose) polymerase inhibitors: impact of adenosine pocket-binding motif appendage to the 3-oxo-2, 3-dihydrobenzofuran-7-carboxamide on potency and selectivity. J Med Chem 62:5330\u20135357","journal-title":"J Med Chem"},{"issue":"3","key":"429_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nbt.2121","volume":"30","author":"E Wahlberg","year":"2012","unstructured":"Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell A-G, Pol E, Frostell \u00c5, Ekblad T, \u00d6nc\u00fc D et al (2012) Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 30(3):283","journal-title":"Nat Biotechnol"},{"issue":"13","key":"429_CR68","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.bmcl.2017.04.089","volume":"27","author":"K Upton","year":"2017","unstructured":"Upton K, Meyers M, Thorsell A-G, Karlberg T, Holechek J, Lease R, Schey G, Wolf E, Lucente A, Sch\u00fcler H et al (2017) Design and synthesis of potent inhibitors of the mono (ADP-ribosyl) transferase, PARP14. Bioorg Med Chem Lett 27(13):2907\u20132911","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"429_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bmcl.2003.10.007","volume":"14","author":"PG Jagtap","year":"2004","unstructured":"Jagtap PG, Southan GJ, Baloglu E, Ram S, Mabley JG, Marton A, Salzman A, Szabo C (2004) The discovery and synthesis of novel adenosine substituted 2, 3-dihydro-1h-isoindol-1-ones: potent inhibitors of poly (ADP-ribose) polymerase-1 (PARP-1). Bioorg Med Chem Lett 14(1):81\u201385","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"429_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap P, Szab\u00f3 C (2005) Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4(5):421","journal-title":"Nat Rev Drug Discov"},{"key":"429_CR71","unstructured":"Tanimoto T (1957) IBM technical report series. Report"},{"issue":"1\u20133","key":"429_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409x(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409x(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"429_CR73","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jmgm.2011.01.004","volume":"29","author":"JD Durrant","year":"2011","unstructured":"Durrant JD, McCammon JA (2011) BINANA: a novel algorithm for ligand-binding characterization. J Mol Graph Model 29(6):888\u2013893. https:\/\/doi.org\/10.1016\/j.jmgm.2011.01.004","journal-title":"J Mol Graph Model"},{"key":"429_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4032","author":"Y Du","year":"2016","unstructured":"Du Y, Yamaguchi H, Wei Y, Hsu JL, Wang HL, Hsu YH, Lin WC, Yu WH, Leonard PG, Lee GR, Chen MK, Nakai K, Hsu MC, Chen CT, Sun Y, Wu Y, Chang WC, Huang WC, Liu CL, Chang YC, Chen CH, Park M, Jones P, Hortobagyi GN, Hung MC (2016) Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. https:\/\/doi.org\/10.1038\/nm.4032","journal-title":"Nat Med"},{"issue":"7","key":"429_CR75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s0089400060498","volume":"6","author":"R Wang","year":"2000","unstructured":"Wang R, Gao Y, Lai L (2000) Ligbuilder: a multi-purpose program for structure-based drug design. J Mol Model 6(7):498","journal-title":"J Mol Model"},{"issue":"5","key":"429_CR76","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/ci100350u","volume":"51","author":"Y Yuan","year":"2011","unstructured":"Yuan Y, Pei J, Lai L (2011) Ligbuilder 2: a practical de novo drug design approach. J Chem Inform Model 51(5):1083\u20131091","journal-title":"J Chem Inform Model"},{"key":"429_CR77","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fchem.2020.00142","volume":"8","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Pei J, Lai L (2020) Ligbuilder v3: a multi-target de novo drug design approach. Front Chem 8:142","journal-title":"Front Chem"},{"key":"429_CR78","volume-title":"Automatic tailoring and transplanting: a practical method that makes virtual screening more useful","author":"Y Li","year":"2011","unstructured":"Li Y, Zhao Y, Liu Z, Wang R (2011) Automatic tailoring and transplanting: a practical method that makes virtual screening more useful. ACS Publications, Washington"},{"issue":"2","key":"429_CR79","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/acs.jcim.5b00691","volume":"56","author":"Y Li","year":"2016","unstructured":"Li Y, Zhao Z, Liu Z, Su M, Wang R (2016) Autot&t v.2: an efficient and versatile tool for lead structure generation and optimization. J Chem Inform Model 56(2):435\u2013453","journal-title":"J Chem Inform Model"},{"issue":"7","key":"429_CR80","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1021\/ci900073k","volume":"49","author":"BC Pearce","year":"2009","unstructured":"Pearce BC, Langley DR, Kang J, Huang H, Kulkarni A (2009) E-novo: an automated workflow for efficient structure-based lead optimization. J Chem Inform Model 49(7):1797\u20131809","journal-title":"J Chem Inform Model"},{"issue":"2","key":"429_CR81","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/ci0503560","volume":"46","author":"U Fechner","year":"2006","unstructured":"Fechner U, Schneider G (2006) Flux (1): a virtual synthesis scheme for fragment-based de novo design. J Chem Inform Model 46(2):699\u2013707","journal-title":"J Chem Inform Model"},{"issue":"2","key":"429_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/ci0496853","volume":"45","author":"SC Sch\u00fcrer","year":"2005","unstructured":"Sch\u00fcrer SC, Tyagi P, Muskal SM (2005) Prospective exploration of synthetically feasible, medicinally relevant chemical space. J Chem Inform Model 45(2):239\u2013248","journal-title":"J Chem Inform Model"},{"issue":"3","key":"429_CR83","first-page":"355","volume":"8","author":"JW Moore","year":"2005","unstructured":"Moore JW (2005) Maximizing discovery efficiency with a computationally driven fragment approach. Curr Opin Drug Disco Dev 8(3):355\u2013364","journal-title":"Curr Opin Drug Disco Dev"},{"issue":"3","key":"429_CR84","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1021\/ci034290p","volume":"44","author":"N Brown","year":"2004","unstructured":"Brown N, McKay B, Gilardoni F, Gasteiger J (2004) A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J Chem Inform Comput Sci 44(3):1079\u20131087","journal-title":"J Chem Inform Comput Sci"},{"issue":"11","key":"429_CR85","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1021\/jm030543u","volume":"47","author":"AC Pierce","year":"2004","unstructured":"Pierce AC, Rao G, Bemis GW (2004) Breed: generating novel inhibitors through hybridization of known ligands. application to CDK2, p38, and HIV protease. J Med Chem 47(11):2768\u20132775","journal-title":"J Med Chem"},{"issue":"2","key":"429_CR86","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/(SICI)1097-0134(20000801)40:2<258::AID-PROT80>3.0.CO;2-I","volume":"40","author":"CM Stultz","year":"2000","unstructured":"Stultz CM, Karplus M (2000) Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin. Proteins Struct Funct Bioinform 40(2):258\u2013289","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"8","key":"429_CR87","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/jm950792l","volume":"39","author":"DA Pearlman","year":"1996","unstructured":"Pearlman DA, Murcko MA (1996) Concerts: dynamic connection of fragments as an approach to de novo ligand design. J Med Chem 39(8):1651\u20131663","journal-title":"J Med Chem"},{"issue":"1","key":"429_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00117275","volume":"9","author":"DE Clark","year":"1995","unstructured":"Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR (1995) Pro ligand: an approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des 9(1):13\u201332","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"429_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00124457","volume":"9","author":"DC Roe","year":"1995","unstructured":"Roe DC, Kuntz ID (1995) Builder v.2: improving the chemistry of a de novo design strategy. J Comput Aided Mol Des 9(3):269\u2013282","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"429_CR90","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"H-J Bohm","year":"1992","unstructured":"Bohm H-J (1992) The computer program ludi: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6(1):61","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"429_CR91","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/BF00126217","volume":"6","author":"HJ Bohm","year":"1992","unstructured":"Bohm HJ (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6(6):593\u2013606","journal-title":"J Comput Aided Mol Des"},{"issue":"7","key":"429_CR92","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/molecules24071444","volume":"24","author":"He Chu","year":"2019","unstructured":"Chu He (2019) MoleGear: a java-based platform for evolutionary de novo molecular design. Molecules 24(7):1444. https:\/\/doi.org\/10.3390\/molecules24071444","journal-title":"Molecules"},{"key":"429_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256","author":"GM Morris","year":"2009","unstructured":"Morris GM, Ruth H, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"30","key":"429_CR94","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/jcc.25052","volume":"38","author":"WJ Allen","year":"2017","unstructured":"Allen WJ, Fochtman BC, Balius TE, Rizzo RC (2017) Customizable de novo design strategies for DOCK: application to HIVgp41 and other therapeutic targets. J Comput Chem 38(30):2641\u20132663. https:\/\/doi.org\/10.1002\/jcc.25052","journal-title":"J Comput Chem"},{"issue":"15","key":"429_CR95","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC (2015) DOCK 6: impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156. https:\/\/doi.org\/10.1002\/jcc.23905","journal-title":"J Comput Chem"},{"issue":"3","key":"429_CR96","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/ci700424b","volume":"48","author":"F Dey","year":"2008","unstructured":"Dey F, Caflisch A (2008) Fragment-based de novo ligand design by multi-objective evolutionary optimization. Supporting Information. J Chem Inf Model 48(3):679\u2013690","journal-title":"J Chem Inf Model"},{"issue":"25","key":"429_CR97","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1021\/jm060838i","volume":"49","author":"P Kolb","year":"2006","unstructured":"Kolb P, Caflisch A (2006) Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking. J Med Chem 49(25):7384\u20137392","journal-title":"J Med Chem"},{"issue":"1","key":"429_CR98","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/(SICI)1097-0134(19991001)37:1<88::AID-PROT9>3.0.CO;2-O","volume":"37","author":"N Majeux","year":"1999","unstructured":"Majeux N, Scarsi M, Apostolakis J, Ehrhardt C, Caflisch A (1999) Exhaustive docking of molecular fragments with electrostatic solvation. Proteins Struct Funct Bioinform 37(1):88\u2013105","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"9","key":"429_CR99","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1515\/BC.2001.168","volume":"382","author":"N Budin","year":"2001","unstructured":"Budin N, Majeux N, Caflisch A (2001) Fragment-based flexible ligand docking by evolutionary optimization. Biol Chem 382(9):1365\u20131372","journal-title":"Biol Chem"},{"issue":"1","key":"429_CR100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","volume":"9","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona M, Blaschke T, Engkvist O, Chen H (2017) Molecular de-novo design through deep reinforcement learning. J Cheminform 9(1):48. https:\/\/doi.org\/10.1186\/s13321-017-0235-x","journal-title":"J Cheminform"},{"key":"429_CR101","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.8b00263","author":"M Skalic","year":"2019","unstructured":"Skalic M, Jim\u00e9nez Luna J, Sabbadin D, De Fabritiis G (2019) Shape-based generative modeling for de-novo drug design. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.8b00263","journal-title":"J Chem Inf Model"},{"key":"429_CR102","volume-title":"Numerical python, UCRL-MA-128569 edn","author":"D Ascher","year":"1999","unstructured":"Ascher D, Dubois PF, Hinsen K, James JH, Oliphant T (1999) Numerical python, UCRL-MA-128569 edn. Lawrence Livermore National Laboratory, Livermore"},{"key":"429_CR103","volume-title":"Guide to NumPy","author":"TE Oliphant","year":"2006","unstructured":"Oliphant TE (2006) Guide to NumPy. Brigham Young University, Provo"},{"key":"429_CR104","unstructured":"Jones E, Oliphant T, Peterson P (2001) Others: SciPy: Open source scientific tools for python. http:\/\/www.scipy.org"},{"issue":"3","key":"429_CR105","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: a 2D graphics environment. Comput Sci Eng 9(3):90","journal-title":"Comput Sci Eng"},{"issue":"5","key":"429_CR106","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jpdc.2007.09.005","volume":"68","author":"L Dalcin","year":"2008","unstructured":"Dalcin L, Paz R, Storti M, D\u2019Elia J (2008) MPI for python: performance improvements and MPI-2 extensions. J Parallel Distrib Comput 68(5):655\u2013662. https:\/\/doi.org\/10.1016\/j.jpdc.2007.09.005","journal-title":"J Parallel Distrib Comput"},{"issue":"2","key":"429_CR107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0004563215595431","volume":"6","author":"H Van De Waterbeemd","year":"1998","unstructured":"Van De Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA (1998) Estimation of blood\u2013brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J Drug Target 6(2):151\u2013165. https:\/\/doi.org\/10.1177\/0004563215595431","journal-title":"J Drug Target"},{"key":"429_CR108","unstructured":"Mozziconacci J, Arnoult E, Baurin N, Marot C, Morin-Allory L (2003) Preparation of a molecular database from a set of 2 million compounds for virtual screening applications: gathering, structural analysis and filtering. In: 9th electronic computational chemistry conference, World Wide Web"},{"issue":"1","key":"429_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1021\/jm901070c","volume":"53","author":"A Jadhav","year":"2010","unstructured":"Jadhav A, Ferreira RS, Klumpp C, Mott BT, Austin CP, Inglese J, Thomas CJ, Maloney DJ, Shoichet BK, Simeonov A (2010) Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem 53(1):37\u201351. https:\/\/doi.org\/10.1021\/jm901070c","journal-title":"J Med Chem"},{"issue":"3","key":"429_CR110","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1039\/c4ob02287d","volume":"13","author":"RG Doveston","year":"2015","unstructured":"Doveston RG, Tosatti P, Dow M, Foley DJ, Li HY, Campbell AJ, House D, Churcher I, Marsden SP, Nelson A (2015) A unified lead-oriented synthesis of over fifty molecular scaffolds. Org Biomol Chem 13(3):859\u2013865. https:\/\/doi.org\/10.1039\/c4ob02287d","journal-title":"Org Biomol Chem"},{"issue":"7","key":"429_CR111","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-020-00429-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T23:35:17Z","timestamp":1618616117000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-020-00429-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1186\/s13321-020-00429-4","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"assertion":[{"value":"3 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}